Related Experiment Video
Updated: Jun 27, 2026

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
Published on: June 30, 2023
Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial
Xinglong Wang1, Bo Su, Sandra L Siedlak
1Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
Abstract:
Mitochondrial dysfunction is a prominent feature of Alzheimer disease but the underlying mechanism is unclear. In this study, we investigated the effect of amyloid precursor protein (APP) and amyloid beta on mitochondrial dynamics in neurons. Confocal and electron microscopic analysis demonstrated that approximately 40% M17 cells overexpressing WT APP (APPwt M17 cells) and more than 80% M17 cells overexpressing APPswe mutant (APPswe M17 cells) displayed alterations in mitochondrial morphology and distribution. Specifically, mitochondria exhibited a fragmented structure and an abnormal distribution accumulating around the perinuclear area. These mitochondrial changes were abolished by treatment with beta-site APP-cleaving enzyme inhibitor IV. From a functional perspective, APP overexpression affected mitochondria at multiple levels, including elevating reactive oxygen species levels, decreasing mitochondrial membrane potential, and reducing ATP production, and also caused neuronal dysfunction such as differentiation deficiency upon retinoic acid treatment. At the molecular level, levels of dynamin-like protein 1 and OPA1 were significantly decreased whereas levels of Fis1 were significantly increased in APPwt and APPswe M17 cells. Notably, overexpression of dynamin-like protein 1 in these cells rescued the abnormal mitochondrial distribution and differentiation deficiency, but failed to rescue mitochondrial fragmentation and functional parameters, whereas overexpression of OPA1 rescued mitochondrial fragmentation and functional parameters, but failed to restore normal mitochondrial distribution. Overexpression of APP or Abeta-derived diffusible ligand treatment also led to mitochondrial fragmentation and reduced mitochondrial coverage in neuronal processes in differentiated primary hippocampal neurons. Based on these data, we concluded that APP, through amyloid beta production, causes an imbalance of mitochondrial fission/fusion that results in mitochondrial fragmentation and abnormal distribution, which contributes to mitochondrial and neuronal dysfunction.
Insights
Amyloid precursor protein (APP) and amyloid beta disrupt mitochondrial dynamics in neurons, causing fragmentation and dysfunction. This imbalance in mitochondrial fission/fusion contributes to Alzheimer disease pathology.
Area of Science:
- Neuroscience
- Cell Biology
- Mitochondrial Biology
Background:
- Mitochondrial dysfunction is a key feature of Alzheimer disease (AD).
- The precise mechanisms linking amyloid precursor protein (APP) and amyloid beta (Aβ) to mitochondrial dysfunction in AD remain unclear.
Purpose of the Study:
- To investigate the impact of APP and Aβ on mitochondrial dynamics and function in neuronal cells.
- To elucidate the molecular mechanisms underlying APP/Aβ-induced mitochondrial alterations.
Main Methods:
- Confocal and electron microscopy to analyze mitochondrial morphology and distribution.
- Assessment of mitochondrial function (ROS levels, membrane potential, ATP production).
- Analysis of key mitochondrial fission/fusion proteins (Drp1, OPA1, Fis1) and rescue experiments.
Main Results:
- APP and Aβ overexpression led to mitochondrial fragmentation and perinuclear accumulation.
- APP/Aβ induced mitochondrial dysfunction, including increased reactive oxygen species and decreased ATP production.
- Altered expression of fission/fusion proteins (decreased Drp1/OPA1, increased Fis1) was observed.
- Overexpression of Drp1 or OPA1 partially rescued specific mitochondrial defects and neuronal dysfunction.
Conclusions:
- APP, via amyloid beta production, disrupts the balance of mitochondrial fission and fusion.
- This imbalance results in mitochondrial fragmentation and abnormal distribution, contributing to neuronal dysfunction in Alzheimer disease.
- Targeting APP/Aβ pathways may offer therapeutic strategies for AD-related mitochondrial deficits.
More Related Videos
10:45A Faster, High Resolution, mtPA-GFP-based Mitochondrial Fusion Assay Acquiring Kinetic Data of Multiple Cells in Parallel Using Confocal Microscopy
Published on: July 20, 2012
15:04Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
Published on: September 28, 2019
Related Concept Videos
ATP Synthase: Mechanism
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Mitochondria
Mitochondrial Membranes
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...